MRIGLOBAL SUPPORTS PRE-CLINICAL DRUG DEVELOPMENT AND MANUFACTURE FOR NATIONAL INSTITUTES OF HEALTH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)
Within NCATS, MRIGlobal Awarded “CRO Support for NCATS Drug Substance and Development” Kansas City, Mo. – MRIGlobal today announced the award of a five-year year program from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS).…
